MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Entity of excessive daytime sleepiness in Parkinson’s disease

    O. Iakovleva, O. Levin, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine frequency and reasons of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Neurodegeneration and dopaminergic medications are known to…
  • 2019 International Congress

    Abnormal posture during treatment of restless legs syndrome in an old woman: A case report

    K. Hirata, K. Suzuki, M. Saito, T. Shiina, H. Sakuramoto, M. Hamaguchi, T. Kadowaki (Mibu, Japan)

    Objective: To report a patient with restless legs syndrome (RLS) in whom abnormal posture appeared during treatment of that. Background: Abnormal posture such as camptocormia…
  • 2019 International Congress

    Restless Leg Syndrome In Men: Examination Of Early Non-Motor Clinical Signs Of Parkinson’s Disease

    M. şenol, M. Karaoğlan, H. Tekeli (Istanbul, Turkey)

    Objective: Restless Legs Syndrome (RLS) is a disorder characterized by an abnormal sensation, some sort of dysesthesia, which cannot be described especially on the limbs.…
  • 2019 International Congress

    Iron Supplementation for the Treatment of Restless Legs Syndrome – A Systematic Review and Meta-Analysis

    M. Kestenbaum, N. Lev (Kfar Saba, Israel)

    Objective: To gather the evidence for the efficacy and safety of iron supplementation for restless legs syndrome (RLS). Background: Iron supplementation is used for the…
  • 2019 International Congress

    Restless leg syndrome in Neuro-Behcet’s and Behcet’s disease

    M. Kuzu Kumcu, S. Erdoğan, M. Sorgun, C. Yücesan (Ankara, Turkey)

    Objective: The goal of this study is the comparison of the restless leg syndrome frequency in the BD and NBD patients and also to investigate…
  • 2019 International Congress

    Profiling of lipoproteins and associated lipids in serum samples from Idiopathic REM Sleep Behavior Disorder patients to identify biomarkers for Parkinson’s disease

    A. Laguna, A. Iranzo, M. Serradell, N. Amigó, O. Yanes, M. Vila (Barcelona, Spain)

    Objective: To perform a lipidomic profile in serum samples from IRBD patients collected before and after their conversion to PD and DLB, in order to…
  • 2019 International Congress

    Distribution Characteristics of Limbs Discomfort in Restless Legs Syndrome

    X. Li, YC. Wu, XY. Zhu (Shanghai, China)

    Objective: To compare the clinical features of RLS patients with asymmetric distribution of discomfort and symmetry distribution, and provide new ideas for the diagnosis and…
  • 2019 International Congress

    Automatic quantification of micro-sleep stability in isolated REM sleep behavior disorder and Parkinson’s disease

    M-L. Muntean, M. Cesari, F. Sixel-Döring, B. Mollenhauer, JAE. Christensen, HBD. Sorensen, PJJ. Jennum, C. Trenkwalder (Kassel, Germany)

    Objective: To investigate micro-sleep stability in patients with Parkinson’s disease (PD) with REM sleep behavior disorder (PD+RBD), PD patients without RBD (PDnoRBD), patients with isolated…
  • 2019 International Congress

    Is Restless Legs Syndrome Usual in Patients with Sickle Cell Disease and Beta Thalassemia?

    E. Okuyucu, M. Guntel, E. Ucar, G. Oktay (Hatay, Turkey)

    Objective: Beta thalassemia and sickle cell disease (SCD) are world-wide heamatologic diseases. The aim of this study is to explore the prevalence and severity of…
  • 2019 International Congress

    Treatment of dopaminergic augmented RLS with Ecopipam, A D1 specific antagonist: an exploratory placebo controlled cross-over trial

    O. Titlayo, W. Ondo (Houston, TX, USA)

    Objective: To establish initial safety and preliminary efficacy of ecopipam, a D1 specific antagonist in patients currently taking dopamine agonist and demonstrating augmentation. Background: Dopamine…
  • « Previous Page
  • 1
  • …
  • 1250
  • 1251
  • 1252
  • 1253
  • 1254
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley